151 related articles for article (PubMed ID: 18563575)
41. Impact of Biopharmaceutics Classification System-based biowaivers.
Cook JA; Davit BM; Polli JE
Mol Pharm; 2010 Oct; 7(5):1539-44. PubMed ID: 20735084
[TBL] [Abstract][Full Text] [Related]
42. Novel high/low solubility classification methods for new molecular entities.
Dave RA; Morris ME
Int J Pharm; 2016 Sep; 511(1):111-126. PubMed ID: 27349790
[TBL] [Abstract][Full Text] [Related]
43. Regional intestinal drug permeation: biopharmaceutics and drug development.
Lennernäs H
Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
[TBL] [Abstract][Full Text] [Related]
44. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
Buckley ST; Frank KJ; Fricker G; Brandl M
Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
[TBL] [Abstract][Full Text] [Related]
45. [Investigations in Bioavailability of resinates as peroral retard drug dosage forms. Part 1: Pharmaceutical availability of dihydrocodein-resinates (author's transl)].
Mühlenbruch B; Strauss H; Glaubitz H
Pharmazie; 1982 Mar; 37(3):200-3. PubMed ID: 7100242
[TBL] [Abstract][Full Text] [Related]
46. Preparation and in vitro release of dual-drug resinates containing equivalent content dextromethorphan and diphenhydramine.
Akkaramongkolporn P; Kulvanich P; Pathipvanich M
Drug Dev Ind Pharm; 2006 Apr; 32(4):483-96. PubMed ID: 16638687
[TBL] [Abstract][Full Text] [Related]
47. In vitro-in vivo correlation strategy applied to an immediate-release solid oral dosage form with a biopharmaceutical classification system IV compound case study.
Bredael GM; Bowers N; Boulineau F; Hahn D
J Pharm Sci; 2014 Jul; 103(7):2125-2130. PubMed ID: 24890761
[TBL] [Abstract][Full Text] [Related]
48. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.
Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W
Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257
[TBL] [Abstract][Full Text] [Related]
49. The influence of dissolution conditions on the drug ADME phenomena.
Cascone S; De Santis F; Lamberti G; Titomanlio G
Eur J Pharm Biopharm; 2011 Oct; 79(2):382-91. PubMed ID: 21515367
[TBL] [Abstract][Full Text] [Related]
50. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
Baghel S; Cathcart H; O'Reilly NJ
J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
[TBL] [Abstract][Full Text] [Related]
51. Intestinal solubility and absorption of poorly water soluble compounds: predictions, challenges and solutions.
Fagerberg JH; Bergström CA
Ther Deliv; 2015; 6(8):935-59. PubMed ID: 26316058
[TBL] [Abstract][Full Text] [Related]
52. Solid state characterization, solid dispersions, solubility enhancement, drug dissolution and drug release.
Alany R
Pharm Dev Technol; 2017 Feb; 22(1):1. PubMed ID: 28117622
[No Abstract] [Full Text] [Related]
53. Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.
Wu CY; Benet LZ
Pharm Res; 2005 Jan; 22(1):11-23. PubMed ID: 15771225
[TBL] [Abstract][Full Text] [Related]
54. Ion exchange resins in the formulation of sustained release medication.
SENSENBACH WE; HAYS EE
Am J Med Sci; 1960 Oct; 240():474-8. PubMed ID: 13750120
[No Abstract] [Full Text] [Related]
55. Effect of sampling procedures of release testing on drug release and scale-up production feasibility of multiple-unit dextromethorphan resinate tablets: a technical note.
Pongjanyakul T
AAPS PharmSciTech; 2007 Dec; 8(4):E117. PubMed ID: 18181538
[TBL] [Abstract][Full Text] [Related]
56. Biopharmaceutic classification of drugs revisited.
Daousani C; Macheras P
Eur J Pharm Sci; 2016 Dec; 95():82-87. PubMed ID: 27496048
[TBL] [Abstract][Full Text] [Related]
57. Interpreting
Rudd ND; Reibarkh M; Fang R; Mittal S; Walsh PL; Brunskill APJ; Forrest WP
Mol Pharm; 2020 May; 17(5):1734-1747. PubMed ID: 32267708
[TBL] [Abstract][Full Text] [Related]
58. Sustained release of drugs from ion exchange resins.
CHAUDHRY NC; SAUNDERS L
J Pharm Pharmacol; 1956 Nov; 8(11):975-83; discussion, 983-6. PubMed ID: 13368094
[No Abstract] [Full Text] [Related]
59. Polymeric delivery systems for biopharmaceuticals.
Dinarvand R; Dorkoosh F; Hamidi M; Moghadam SH
Biotechnol Genet Eng Rev; 2004; 21():147-81. PubMed ID: 17017031
[No Abstract] [Full Text] [Related]
60. Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs.
Yu LX; Carlin AS; Amidon GL; Hussain AS
Int J Pharm; 2004 Feb; 270(1-2):221-7. PubMed ID: 14726137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
